Finnish health tech startup CurifyLabs has secured €12 million in Series A funding, co-led by Sandwater and HealthCap, with participation from Tesi and Lifeline Ventures. This funding will fuel expansion into the U.S. market and accelerate development of their automated personalized medicine manufacturing platform, which is currently utilized by pharmacies in twenty-one U.S. states and across Europe. The capital will also be invested in strengthening their supply chain and enhancing customer support for their growing network of pharmacy partners.